Press Release: Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board
Retrieved on:
Monday, April 4, 2022
People, Sodexo, Human, ERG, Organization, Culture, NASDAQ, Leadership, NBA, Royal Society for Public Health, Ethics, Chartered Scientist, Royal Society, Business, Board, SNY, Rotation, Organic, Intelligence, Social responsibility, Environment, Erg, International Agency for Research on Cancer, Medicine, Public health, Senior, Corporate responsibility, DE, University of East London, Business Integration Group, Inc., General counsel, Equity, Science, Employee resource group, General Medicine Faculty of RostGMU (Rostov State Medical University), Chief experience officer, Founder, SAN, Research and development, History, Management, Risk management, Rohini, Visual impairment, Vaccine, Sanofi
Sanofi launches today its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors.
Key Points:
- Sanofi launches today its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors.
- Were committed to driving diversity, equity and inclusion in Sanofi and beyond.
- The DE&I Board will meet 3 times per year and progress on the 2025 targets will continue to be communicated on a quarterly basis.
- Its a real honour to be joining the Sanofi DE&I Board which will support the strategic evolution of Business Inclusion focusing on the complex intersectional nature of diversity, equity, and inclusion.